Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.27% | 2.96% | 17.04% | 35.67% | 56.60% |
| Total Depreciation and Amortization | -2.16% | 1.52% | 5.78% | 29.07% | 60.39% |
| Total Amortization of Deferred Charges | 815.30% | 815.30% | 815.30% | 395.48% | -4.26% |
| Total Other Non-Cash Items | 283.18% | 870.58% | 691.57% | 56.64% | -214.21% |
| Change in Net Operating Assets | -691.40% | -691.40% | -691.40% | -1,901.19% | 180.50% |
| Cash from Operations | -41.92% | -37.62% | -32.41% | 12.62% | 76.79% |
| Capital Expenditure | 36.13% | 36.13% | 36.13% | -11.07% | -110.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 34.85% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.83% | -183.25% | -698.42% | -415.61% | -113.06% |
| Cash from Investing | 50.26% | -27.36% | -121.59% | -117.93% | -111.93% |
| Total Debt Issued | 53.88% | 53.88% | 53.88% | 93.74% | 222.15% |
| Total Debt Repaid | -16.64% | -16.64% | -16.64% | -79.70% | -386.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -380.61% | -380.61% | -380.61% | -480.61% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -332.53% | -345.55% | -51.85% | 381.22% | 427.71% |
| Cash from Financing | -154.26% | -98.56% | 13.41% | 169.20% | 1,098.29% |
| Foreign Exchange rate Adjustments | 183.78% | 172.87% | 158.52% | 62.79% | -33.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.54% | -153.71% | -308.21% | -114.04% | 319.03% |